Presenting
Burford Capital
Burford Capital Limited (BUR) is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Capital provision, which is the provision of capital to the legal industry or in connection with legal matters, both directly and through investment in the groups managed funds; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance . Geographical segments include, USA, UK, Singapore, Hong Kong, China, and, Australia.
Learning Technologies Group
Learning Technologies Group plc was created in 2013 by a highly experienced team of successful corporate leaders and learning technologies professionals to provide a comprehensive and integrated range of e-learning services and technologies to corporate and government clients. LTG is making good progress towards its goal of establishing a substantial global organisation of specialist digital learning businesses from Europe, US, Latin America and Asia to form a market-leading learning technologies agency.
Synairgen
Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.
The business, focused primarily on severe asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic Key Opinion Leader network to discover and develop novel therapies for respiratory disease.
TyraTech
TyraTech, Inc. was established in 2004 and has developed a unique patented technology to enhance the activity of plant-based ingredients against insects and parasites.
In 2014, TyraTech launched Vamousse® head lice treatment and shampoo, now stocked in 20,000 stores in the USA & 7,000 stores in the UK. With Vamousse, TyraTech has unlocked the value of its technology platform and shown that its products can be a commercial success.
The commercial success of the Vamousse head lice range can be reproduced in significantly larger markets eg insect control in livestock premises.
TyraTech, Inc. made its Initial Public Offering in June 2007 on AIM, where it trades under two separate common stock share listings (TYR and TYRU).
